期刊文献+

北京地区成人社区获得性肺炎患者中肺炎支原体耐药情况的多中心调查 被引量:56

Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China
原文传递
导出
摘要 目的 了解北京地区成人社区获得性肺炎(CAP)患者中肺炎支原体对大环内酯等常用抗生素的耐药情况.方法 收集2010年9月至2012年6月北京地区3家医院就诊的CAP患者.采集咽拭子标本进行肺炎支原体培养.对分离到的肺炎支原体菌株进行体外药敏试验及对大环内酯类耐药相关基因突变位点检测.结果 321例患者纳入本研究,共分离出肺炎支原体53株,其中红霉素耐药38株(71.7%);阿奇霉素耐药32株(60.4%);未发现对喹诺酮及四环素类药物耐药的菌株.A2063G点突变是导致对大环内酯类抗生素耐药的主要点突变.结论 北京地区成人CAP肺炎支原体对大环内酯类抗生素耐药率高,未发现喹诺酮及四环素类耐药菌株. Objective To explore the tendency of macrolide resistance in Mycoplasma pneumoniae infection in community-acquired pneumonia (CAP) patients in Beijing. Methods Adult CAP patients of ≥18 yrs were enrolled in 3 medical centers in Beijing , China. Throat swab samples were taken from all the patients to perform the culture of M. pneumoniae. All the isolated M. pneumoniae strains were subjected to susceptibility evaluation for 6 agents, including macrolides such as erythromycin and azithromycin. In strains showing macrolide resistance, the 23S rRNA gene was analyzed. Results A total 53 strains of M. pneumoniae were isolated from 321 enrolled patients. Thirty-eight of the isolated strains (71.7%) were resistant to erythromycin and 32 of them ( 60. 4% ) were resistant to azithromycin. Six strains with moderate or low level of erythromycin-resistance were still susceptible to azithromycin. No fluoroquinolone- resistant or tetracycline-resistant strains were observed in our study. Point transition of A2063G in the 23S ribosomal RNA gene was the main reason for the high prevalence of macrolide resistance. Conclusions The prevalence of macrolide resistance in M. pneumoniae is very high in adult CAP patients in Beijing. Studies are needed to clarify the clinical meaning of prevalence of macrolide-resistant M. pneumoniae in adults CAP patients.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2013年第12期954-958,共5页 Chinese Journal of Tuberculosis and Respiratory Diseases
关键词 肺炎 支原体 大环内酯 抗药性 Pneumonia, mycoplasma Macrolides Drug resistance
  • 相关文献

参考文献2

二级参考文献47

  • 1Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153. 被引量:1
  • 2Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545. 被引量:1
  • 3Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301. 被引量:1
  • 4Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754. 被引量:1
  • 5Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408. 被引量:1
  • 6Polverino E, Torres Marti A. Community-acquired pneumonia. Minerva anestesiologica 2011 ; 77:196-211. 被引量:1
  • 7Apisarnthanarak A, Mundy LM. Etiology of community-acquired pneumonia. Clin Chest Med 2005; 26: 47-55. 被引量:1
  • 8Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67: 71-79. 被引量:1
  • 9Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther 1998; 20: 820-837. 被引量:1
  • 10Monte SV, Paolini NM, Slazak EM, Schentag J J, Paladino JA. Costs of treating lower respiratory tract infections. Am J Manag Care 2008; 14: 190-196. 被引量:1

共引文献840

同被引文献495

引证文献56

二级引证文献3335

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部